## Clinical Diagnosis This patient presents with **septic shock** secondary to community-acquired pneumonia (CAP). The diagnostic criteria are met: - Infection (fever, respiratory symptoms, bilateral infiltrates) - Hypotension (SBP 88–92 mmHg despite fluid resuscitation) - Tissue hypoperfusion (elevated lactate 4.2 mmol/L, elevated creatinine) ## Septic Shock Management Algorithm ```mermaid flowchart TD A[Suspected sepsis]:::outcome --> B[Early recognition & cultures]:::action B --> C[Fluid resuscitation 30 mL/kg]:::action C --> D{BP adequate?}:::decision D -->|Yes| E[Reassess, continue antibiotics]:::action D -->|No| F{Lactate improving?}:::decision F -->|Yes| G[Continue fluids cautiously]:::action F -->|No| H[Initiate vasopressor]:::action H --> I[Norepinephrine first-line]:::action I --> J[Target MAP ≥65 mmHg]:::action J --> K[Reassess lactate, urine output]:::action ``` ## Rationale for Vasopressor Initiation **Key Point:** According to the Surviving Sepsis Campaign (SSC) guidelines, vasopressors are indicated when hypotension persists despite adequate fluid resuscitation (30 mL/kg crystalloid). **High-Yield:** In this case: - Initial fluid bolus (30 mL/kg) has been given - Blood pressure remains low (92/56 mmHg) - Lactate has only marginally improved (4.2 → 3.8 mmol/L) - This indicates **persistent tissue hypoperfusion** despite fluid therapy **Clinical Pearl:** Norepinephrine is the first-line vasopressor in septic shock because it combines α-adrenergic (vasoconstriction) and β-adrenergic (inotropic) effects, improving both perfusion pressure and cardiac output. ## Why Norepinephrine Is Preferred | Agent | Mechanism | Use in Sepsis | |-------|-----------|---------------| | Norepinephrine | α > β effects | **First-line** — improves MAP and CO | | Dopamine | Dose-dependent | Second-line; risk of tachyarrhythmias | | Epinephrine | α = β effects | Reserved for refractory shock | | Phenylephrine | Pure α | Avoid — reduces cardiac output | **Mnemonic:** NAPE — **N**orepinephrine (first-line), **A**ddress fluids first, **P**erfusion targets (MAP ≥65), **E**arly antibiotics. ## Concurrent Management - **Antibiotics:** Broad-spectrum coverage (e.g., ceftriaxone + azithromycin or fluoroquinolone) must be started immediately (within 1 hour of recognition). - **Source control:** Imaging (CXR done; consider CT if unclear). - **Lactate monitoring:** Repeat lactate at 2–4 hours; persistent elevation despite vasopressor indicates poor prognosis. **Warning:** Do NOT delay vasopressor initiation while awaiting further fluid response — persistent hypotension with tissue hypoperfusion (elevated lactate) mandates vasopressor support. 
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.